Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67


Involment of RAS/ERK1/2 signaling and MEF2C in miR-155-3p inhibition-triggered cardiomyocyte differentiation of embryonic stem cell.

Ling X, Yao D, Kang L, Zhou J, Zhou Y, Dong H, Zhang K, Zhang L, Chen H.

Oncotarget. 2017 Sep 23;8(48):84403-84416. doi: 10.18632/oncotarget.21218. eCollection 2017 Oct 13.


Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.

Chen XY, Lv RJ, Zhang W, Yan YG, Li P, Dong WQ, Liu X, Liang ES, Tian HL, Lu QH, Zhang MX.

Oncotarget. 2016 May 24;7(21):31053-66. doi: 10.18632/oncotarget.8842.


ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells.

Lu Q, Schnitzler GR, Ueda K, Iyer LK, Diomede OI, Andrade T, Karas RH.

PLoS One. 2016 Apr 1;11(4):e0152807. doi: 10.1371/journal.pone.0152807. eCollection 2016.


A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.

Kim BW, More SV, Yun YS, Ko HM, Kwak JH, Lee H, Suk K, Kim IS, Choi DK.

Acta Pharmacol Sin. 2016 Mar;37(3):334-43. doi: 10.1038/aps.2015.138. Epub 2016 Feb 1.


Systematic discovery of linear binding motifs targeting an ancient protein interaction surface on MAP kinases.

Zeke A, Bastys T, Alexa A, Garai Á, Mészáros B, Kirsch K, Dosztányi Z, Kalinina OV, Reményi A.

Mol Syst Biol. 2015 Nov 3;11(11):837. doi: 10.15252/msb.20156269.


Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.

Gardner S, Gross SM, David LL, Klimek JE, Rotwein P.

Am J Physiol Cell Physiol. 2015 Oct 1;309(7):C491-500. doi: 10.1152/ajpcell.00184.2015. Epub 2015 Aug 5.


Dynamic single cell measurements of kinase activity by synthetic kinase activity relocation sensors.

Durandau E, Aymoz D, Pelet S.

BMC Biol. 2015 Aug 1;13:55. doi: 10.1186/s12915-015-0163-z.


Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.

Parvani JG, Davuluri G, Wendt MK, Espinosa C, Tian M, Danielpour D, Sossey-Alaoui K, Schiemann WP.

Neoplasia. 2015 Mar;17(3):317-28. doi: 10.1016/j.neo.2015.02.003.


Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB.

Jain P, Lavorgna A, Sehgal M, Gao L, Ginwala R, Sagar D, Harhaj EW, Khan ZK.

Retrovirology. 2015 Feb 27;12:23. doi: 10.1186/s12977-015-0140-1.


Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization.

Zhang L, Sun Y, Fei M, Tan C, Wu J, Zheng J, Tang J, Sun W, Lv Z, Bao J, Xu Q, Yu H.

Autophagy. 2014 Jun;10(6):1015-35. doi: 10.4161/auto.28477.


Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Koul HK, Pal M, Koul S.

Genes Cancer. 2013 Sep;4(9-10):342-59. doi: 10.1177/1947601913507951. Review.


Molecular basis of MAP kinase regulation.

Peti W, Page R.

Protein Sci. 2013 Dec;22(12):1698-710. doi: 10.1002/pro.2374. Epub 2013 Oct 19. Review.


Modulation of lysine methylation in myocyte enhancer factor 2 during skeletal muscle cell differentiation.

Choi J, Jang H, Kim H, Lee JH, Kim ST, Cho EJ, Youn HD.

Nucleic Acids Res. 2014 Jan;42(1):224-34. doi: 10.1093/nar/gkt873. Epub 2013 Sep 27.


Modulation of lipid metabolic defects rescues cleft palate in Tgfbr2 mutant mice.

Iwata J, Suzuki A, Pelikan RC, Ho TV, Sanchez-Lara PA, Chai Y.

Hum Mol Genet. 2014 Jan 1;23(1):182-93. doi: 10.1093/hmg/ddt410. Epub 2013 Aug 23.


Preventing p38 MAPK-mediated MafA degradation ameliorates β-cell dysfunction under oxidative stress.

El Khattabi I, Sharma A.

Mol Endocrinol. 2013 Jul;27(7):1078-90. doi: 10.1210/me.2012-1346. Epub 2013 May 9.


Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove.

Garai Á, Zeke A, Gógl G, Törő I, Fördős F, Blankenburg H, Bárkai T, Varga J, Alexa A, Emig D, Albrecht M, Reményi A.

Sci Signal. 2012 Oct 9;5(245):ra74. doi: 10.1126/scisignal.2003004.


Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson's Disease.

Yin Y, She H, Li W, Yang Q, Guo S, Mao Z.

Front Physiol. 2012 May 29;3:171. doi: 10.3389/fphys.2012.00171. eCollection 2012.


p38 MAPK activation, JNK inhibition, neoplastic growth inhibition, and increased gap junction communication in human lung carcinoma and Ras-transformed cells by 4-phenyl-3-butenoic acid.

Matesic DF, Sidorova TS, Burns TJ, Bell AM, Tran PL, Ruch RJ, May SW.

J Cell Biochem. 2012 Jan;113(1):269-81. doi: 10.1002/jcb.23353.


Mechanisms of specificity in neuronal activity-regulated gene transcription.

Lyons MR, West AE.

Prog Neurobiol. 2011 Aug;94(3):259-95. doi: 10.1016/j.pneurobio.2011.05.003. Epub 2011 May 18. Review.


Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9.

Boston SR, Deshmukh R, Strome S, Priyakumar UD, MacKerell AD Jr, Shapiro P.

BMC Cancer. 2011 Jan 10;11:7. doi: 10.1186/1471-2407-11-7.

Supplemental Content

Support Center